Skip to main content
Log in

Clinicopathological Analysis of B Cell Lymphomas, Unclassifiable; with Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma in a Tertiary Care Hospital in Southern India

  • Original Article
  • Published:
Indian Journal of Hematology and Blood Transfusion Aims and scope Submit manuscript

Abstract

B-cell lymphomas, unclassifiable; with features intermediate between large B-cell lymphoma and Burkitt lymphoma (BCLu-DLBCL/BL) is a new entity included in the recent World Health Organization (WHO) classification of Tumours of the Hematopoietic and Lymphoid Tissues (2008) to overcome the problems of difficulty in classifying certain lymphomas having overlapping morphological, immunophenotypical and genetic features. To study the clinicopathological profile of BCLu-DLBCL/BL. Cross-sectional study over 3 year period in the Haematology section of Department of Pathology in a large teaching hospital in Southern India from January 2011 to December 2013. All the cases reported as BCLu-DLBCL/BL were collected and the clinical, morphological and immunohistochemical parameters were analyzed. Descriptive statistics. There were seven cases, four males and three females, of age ranging from 20 to 70 years. Five cases had extranodal involvement. Four cases had Burkitt morphology with strong Bcl2 positivity and absent CD10 expression. One case had the morphology and immunophenotype that of typical BL, along with strong positivity to Bcl2 suggesting a double hit hypothesis. Two cases had morphology and immunophenotype of BL with low Ki 67. Three patients on follow up had adverse outcome. BCLu-DLBCL/BL, a provisional category in WHO 2008 is useful in classifying the cases not meeting the criteria for classical BL or DLBCL. Each of these cases was interesting with different sites of involvement, different morphological features and immunophenotype with most of the patients on follow up ending with a grave prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Kluin PM, Harris NL, Stein H, Leoncini L, Raphael M, Campo E et al (2008) B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. In: Swerdlow SH, Campo E et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC Press, Lyon, pp 265–266

    Google Scholar 

  2. Rudiger T, Jaffe ES, Delsol G, deWolf-Peeters C, Gascoyne RD, Georgii A et al (1998) Workshop report on Hodgkin’s disease and related diseases (‘grey zone’ lymphoma). Ann Oncol 9:S31–S38

    Article  PubMed  Google Scholar 

  3. Aukema SM, Siebert R, Schuuring E, van Imhoff GW, Kluin-Nelemans HC, Boerma EJ et al (2011) Double-hit B-cell lymphomas. Blood 117:2319–2331

    Article  CAS  PubMed  Google Scholar 

  4. Carbone A, Gloghini A, Aiello A, Testi A, Cabras A (2010) B-cell lymphomas with features intermediate between distinct pathologic entities. From pathogenesis to pathology. Hum Pathol 41:621–631

    Article  CAS  PubMed  Google Scholar 

  5. Quintanilla-Martinez L, de Jong D, de Mascarel A, Hsi ED, Kluin P, Natkunam Y et al (2009) Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France. J Hematop 2:211–236

    Article  PubMed  PubMed Central  Google Scholar 

  6. Le Gouill S, Talmant P, Touzeau C, Moreau A, Garand R, Juge-Morineau N et al (2007) The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement. Haematologica 92:1335–1342

    Article  PubMed  Google Scholar 

  7. Bellan C, Stefano L, de Giulia F, Rogena EA, Lorenzo L (2009) Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach. Hematol Oncol 27:182–185

    Article  PubMed  Google Scholar 

  8. Hasserjian RP, Ott G, Elenitoba-Johnson KS, Balague-Ponz O, de Jong D, de Leval L (2009) Commentary on the WHO classification of tumors of lymphoid tissues (2008): “Gray zone” lymphomas overlapping with Burkitt lymphoma or classical Hodgkin lymphoma. J Hematop 2:89–95

    Article  PubMed  PubMed Central  Google Scholar 

  9. Cigudosa JC, Parsa NZ, Louie DC, Filippa DA, Jhanwar SC, Johansson B et al (1999) Cytogenetic analysis of 363 consecutively ascertained diffuse large B-cell lymphomas. Genes Chromosom Cancer 25:123–133

    Article  CAS  PubMed  Google Scholar 

  10. Savage KJ, Johnson NA, Ben-Neriah S, Connors JM, Sehn LH, Farinha P et al (2009) MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy. Blood 114:3533–3537

    Article  CAS  PubMed  Google Scholar 

  11. Barrans S, Crouch S, Smith A, Turner K, Owen R, Patmore R et al (2010) Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab. J Clin Oncol 28:3360–3365

    Article  CAS  PubMed  Google Scholar 

  12. Salaverria I, Siebert R (2011) The gray zone between Burkitt’s lymphoma and diffuse large B-cell lymphoma from a genetics perspective. J ClinOncol 29:1835–1843

    Article  Google Scholar 

  13. Johnson NA, Savage KJ, Ludkovski O, Ben-Neriah S, Woods R, Steidl C et al (2009) Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival. Blood 114:2273–2279

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Poirel HA, Cairo MS, Heerema NA, Swansbury J, Aupérin A, Launay E et al (2009) Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin’s lymphoma: Results of the FAB/LMB 96 international study. Leukemia 23:323–331

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Boerma EG, Siebert R, Kluin PM, Baudis M (2009) Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: A historical review of cytogenetics in the light of todays knowledge. Leukemia 23:225–234

    Article  CAS  PubMed  Google Scholar 

  16. Klapper W, Szczepanowski M, Burkhardt B, Berger H, Rosolowski M, Bentink S et al (2008) Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials. Blood 112:1374–1381

    Article  CAS  PubMed  Google Scholar 

  17. Perry AM, Crockett D, Dave BJ, Althof P, Winkler L, Smith LM et al (2013) B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and burkitt lymphoma: study of 39 cases. Br J Haematol 162(1):40–49

    Article  CAS  PubMed  Google Scholar 

  18. Bürgesser MV, Gualco G, Diller A, Natkunam Y, Bacchi CE (2013) Clinicopathological features of aggressive B-cell lymphomas including B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell and Burkitt lymphomas: a study of 44 patients from Argentina. Ann Diagn Pathol 17(3):250–255

    Article  PubMed  Google Scholar 

  19. Edwards L, Krakow F, Bhagirath VC, Christine Keng C, Lytwyn A (2014) B-cell Lymphoma Unclassifiable with Features Intermediate between Diffuse Large B-cell Lymphoma and Burkitt’s Lymphoma: Comparison study of clinical outcome and treatment response. J Clin Anat Pathol 2:1–8

    Google Scholar 

  20. Jaradat JM, Potluri A, Bilodeau EA (2013) B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma: Report of a case in the oral cavity. Indian J Dent Res 24:384–386

    Article  PubMed  Google Scholar 

  21. Ahn JY, Seo YH, Park PW, Kim KH, Park MJ, Jeong JH et al (2012) A case of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma in a Korean child. Ann Lab Med 32:162–166

    Article  PubMed  PubMed Central  Google Scholar 

  22. Zhang S, Wilson D, Czader M (2015) Pediatric B-cell lymphoma, unclassifiable, with intermediate features between those of diffuse large B-cell lymphoma and Burkitt lymphoma: a report of two cases. Ann Lab Med 35(2):254

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Conflict of interest

None declared.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Subramanian Kalaivani Selvi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Selvi, S.K., Kar, R., Basu, D. et al. Clinicopathological Analysis of B Cell Lymphomas, Unclassifiable; with Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma in a Tertiary Care Hospital in Southern India. Indian J Hematol Blood Transfus 32, 168–175 (2016). https://doi.org/10.1007/s12288-015-0558-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12288-015-0558-6

Keywords

Navigation